Hypoxia-inducible factor-1α induces cell cycle arrest of endothelial cells

Genes to Cells

Volumn 7, Issue 2, 2002, Pages 143-149

  Iida, Takeshi ^a   Mine, Shinichiro ^a   Fujimoto, Hiroko ^b   Suzuki, Koji ^c   Minami, Yasuhiro ^b   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOSOME; PROTEIN BCL 2; PROTEIN P21;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; MITOSIS INHIBITION; PRIORITY JOURNAL; TISSUE INJURY;

APOPTOSIS; CELL CYCLE; CELL HYPOXIA; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GENES, BCL-2; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; TRANSCRIPTION FACTORS;

VECTORS;

EID: 0036195349     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1356-9597.2001.00512.x     Document Type: Article

References (30)

1. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
2. Phosphorylation of the retinoblastoma protein by cdk2
3. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
4. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
5. Endothelial cell apoptosis in angiogenesis and vessel regression
6. Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the Arnt transcription factor
7. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53
8. Cloning of a factor required for activity of the Ah (dioxin) receptor
9. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
10. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1
11. Apoptosis in atherosclerosis: Beneficial or detrimental?
12. A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc
13. Hypoxia-induced endothelial apoptosis through nuclear factor-κB (NF-κB)-mediated bcl-2 suppression: In vivo evidence of the importance of NF-κB in endothelial cell regulation
14. Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation
15. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation
16. Apoptosis in the vascular wall and atherosclerosis
17. Expression of hypoxia-inducible factor 1: Mechanisms and consequences
18. HIF-1 and human disease: One highly involved factor
19. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
20. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
21. Lymphocyte interactions with endothelial cells
22. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis
23. Integrin activation by chemokines: Relevance to inflammatory adhesion cascade during T cell migration
24. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta
25. Heparan sulphate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid synovitis
26. Distinct phenotype of leukemic T cells with various tissue tropisms
27. Activation of p53 and its target genes p21 (WAF1/Cip1) and PAG608/Wig-1 in ischemic preconditioning
28. 2 tension
29. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia
30. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of p21 (wafl/cip1), and erythropoietin